“31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age” (2022) SKIN The Journal of Cutaneous Medicine, 6(2), p. s24. doi:10.25251/skin.6.supp.24.